Neuropsychiatric symptoms in the dementias

Current Opinion in Neurology

Volumn 15, Issue 4, 2002, Pages 445-450

  Assal, Frédéric ^a   Cummings, Jeffrey L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Dementia with Lewy bodies; Frontotemporal dementia; Neuropsychiatric symptoms; Parkinson's disease

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; GABAPENTIN; GALANTAMINE; HALOPERIDOL; METRIFONATE; MUSCARINIC M2 RECEPTOR; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; RIVASTIGMINE; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER;

ALZHEIMER DISEASE; APATHY; BEHAVIOR; DEMENTIA; DEPRESSION; DIAGNOSTIC IMAGING; EXTRAPYRAMIDAL SYMPTOM; FRONTOTEMPORAL DEMENTIA; GENETICS; HUMAN; LEWY BODY; NEUROPSYCHIATRY; PALLIATIVE THERAPY; PARKINSON DISEASE; PATHOLOGY; PSYCHOSIS; REVIEW; RISK FACTOR; SYMPTOMATOLOGY;

ALZHEIMER DISEASE; DEPRESSION; HUMANS; PSYCHOTIC DISORDERS;

EID: 0036315509     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200208000-00007     Document Type: Review

References (56)

1. Behavioral symptoms in Alzheimer's disease: Phenomenology and treatment
2. The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
3. Frontotemporal lobar degeneration. A consensus on clinical diagostic criteria
4. Consensus guidelines for the clinical and pathologic diagnosis of newly proposed clinical criteria for dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
5. Caregiver report of hallucinations and paranoid delusions in elders aged 70 or older
6. Psychotic symptoms and paranoid ideation in a nondemented population-based sample of the very old
7. The spectrum of behavioral changes in Alzheimer's disease
8. Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: The Cache County Study
9. An evidence-based proposal for the classification of neuropsychiatric disturbance in Alzheimer's disease
10. Syndromic validity of apathy in Alzheimer's disease
11. Relationship of psychosis to aggression, apathy and function in dementia
12. An investigation of visual hallucinosis and visual sensory status in dementia
13. Verbal aggression in Alzheimer's disease. Clinical, functional and neuropsychological correlates
14. Depressive symptoms in patients with Alzheimer's disease
15. Anxiety and Alzheimer's disease
16. Perfusion brain SPECT and statistical parametric mapping analysis indicate that apathy is a cingulate syndrome: A study in Alzheimer's disease and nondemented patients
17. Psychiatric symptoms associated with cortical-subcortical dysfunction in Alzheimer's disease
18. Frontal lobe hypometabolism and depression in Alzheimer's disease
19. The psychotic phenomenon in probable Alzheimer's disease: A positron emission tomography study
20. Alteration of rCBF in Alzheimer's disease patients with delusions of theft
21. Cerebral correlates of psychotic symptoms in Alzheimer's disease
22. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment
23. Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease
24. Suicide and Alzheimer's pathology in the elderly: A case-control study
25. Cognitive impairment in depression is not associated with neuropathological evidence of increased vascular or Alzheimer-type pathology
26. Psychosis of Alzheimer's disease is associated with elevated muscarinic M2 binding in the cortex
27. Psychosis and aggression in Alzheimer's disease: The effect of dopamine receptor gene variation
28. The 5-HTTPR *S/*L polymorphism and aggressive behavior in Alzheimer disease
29. Association between 5-HT2A receptor polymorphism and psychotic symptoms in Alzheimer's disease
30. A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease
31. Donepezil for the treatment of behavioral disturbances in Alzheimer's disease: A 6-month open trial
32. Efficacy of metrifonate in improving the psychiatric and behavioral disturbances in patients with Alzheimer's disease
33. Cognitive and metabolic responses to metrifonate therapy in Alzheimer disease
34. A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioral and psychological symptoms in Chinese dementia patients
35. Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in nursing home patients with Alzheimer's dementia
36. Olanzapine in the treatment of anxiety symptoms due to Alzheimer's disease: A post hoc analysis
37. Gabapentin as a possible treatment of behavioral alterations in Alzheimer disease (AD) patients
38. Behavior in frontotemporal dementia, Alzheimer's disease and vascular dementia
39. Distinct behavioral profiles in frontotemporal dementia and semantic dementia
40. The influence of right frontotemporal dysfunction on social behavior in frontotemporal dementia
41. Neuroanatomy of the self. Evidence from patients with frontotemporal dementia
42. Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: Preliminary findings from an open trial
43. Long-term use of rivastigmine in patients with dementia with Lewy bodies: An open-label trial
44. A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia
45. Visual hallucinations in Parkinson's disease: A review and phenomenological survey
46. Prospective study of hallucinations and delusions in Parkinson's disease
47. Prospective longitudinal assessment of hallucinations in Parkinson's disease
48. Genetic variation analysis in Parkinson disease patients with and without hallucinations
49. Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease
50. Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsy
51. Neuropsychiatric aspects of Huntington's disease
52. Behavioral changes in Huntington disease
53. Psychiatric symptoms and CAG repeats in neurologically asymptomatic Huntington's disease gene carriers
54. Cortical changes in Alzheimer's disease detected with a disease-specific population-based brain atlas
55. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease
56. In-vivo measurement of activated microglia in dementia